PGP Farmer, the French biotech building the country’s first EU-GMP medical cannabis production site, has narrowed a 30-variety Dutch phenotyping trial to five elite cultivars, laying the agronomic groundwork for its 9-hectare Dordogne facility as France closes on the reforms needed for full medical cannabis rollout.
Today (February 19, 2026), Cannabis Europa returns to the French capital for the first time since 2019 at a critical juncture for the incoming French medical cannabis industry.
French authorities will present a first draft of the long-awaited pricing and reimbursement decree for medical cannabis on February 18, marking a critical milestone in the country’s drawn-out transition from pilot programme to permanent framework.
PGP Farmer closes a €3m funding round to become a leading player in EU-GMP medical cannabis production in Europe French biotech company PGP Farmer unveils the closing of a €3 million funding round with private investors.
Thousands of French medical cannabis patients will continue to receive their treatment for the foreseeable future, as the highly anticipated full generalised framework edges towards reality.
A comprehensive cross-section of the world’s most influential policymakers and global regulatory officials are set to meet with a group of the cannabis industry’s leading voices for an unprecedented inaugural global summit.
Following months of uncertainty and doubt, thousands of medical cannabis patients in France can now breathe a sigh of relief after the government finally confirmed that access to their treatment will continue.
The future of France’s medical cannabis programme has been thrown into doubt this week as the government failed to introduce any sort of regulatory framework or allocate any funding in its annual budget.
FRENCH authorities have implemented a new ‘temporary framework’ for CBD allowing it to be registered and sold as a food supplement for the first time.
